Research and Insights

Capital ideas from the industry’s brightest minds.

In Equity Research, our award-winning analysts deliver superior investment ideas and value-added perspective for nearly 600 quality growth companies.

Under Insights, you will find firm publications, market commentaries, and white papers from our investment banking and asset management professionals.

Over the last 10 years, major changes in diabetes device sales have been driven by those solutions that have demonstrated an ability to improve glycemic control (as measured by HbA1c reduction or time-in-range).